<h4>Background</h4>Many studies have investigated the prognostic role of the C-reactive protein/albumin ratio (CRP/Alb ratio) in patients with gynecological cancers; however, there is lack of consensus owing to conflicting results across studies. This evidence concerns the gene CRP and female reproductive organ cancer.